Cwm LLC Acquires 16,103 Shares of UnitedHealth Group Incorporated $UNH

Cwm LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.7% during the second quarter, HoldingsChannel.com reports. The fund owned 133,461 shares of the healthcare conglomerate’s stock after acquiring an additional 16,103 shares during the period. Cwm LLC’s holdings in UnitedHealth Group were worth $41,636,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. OFI Invest Asset Management increased its holdings in UnitedHealth Group by 4.9% during the 2nd quarter. OFI Invest Asset Management now owns 71,375 shares of the healthcare conglomerate’s stock worth $22,267,000 after acquiring an additional 3,335 shares during the period. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. increased its holdings in UnitedHealth Group by 4.8% during the 2nd quarter. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. now owns 8,168 shares of the healthcare conglomerate’s stock worth $2,548,000 after acquiring an additional 375 shares during the period. Vanguard Personalized Indexing Management LLC increased its holdings in UnitedHealth Group by 1.7% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 100,498 shares of the healthcare conglomerate’s stock worth $31,376,000 after acquiring an additional 1,645 shares during the period. Lincluden Management Ltd. grew its stake in UnitedHealth Group by 73.1% in the 2nd quarter. Lincluden Management Ltd. now owns 14,408 shares of the healthcare conglomerate’s stock worth $4,495,000 after buying an additional 6,084 shares in the last quarter. Finally, Sather Financial Group Inc grew its stake in UnitedHealth Group by 1,252.5% in the 2nd quarter. Sather Financial Group Inc now owns 20,585 shares of the healthcare conglomerate’s stock worth $6,422,000 after buying an additional 19,063 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 3.6%

NYSE:UNH opened at $354.30 on Friday. The company has a fifty day moving average of $318.21 and a 200 day moving average of $349.25. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $320.88 billion, a P/E ratio of 15.35, a P/E/G ratio of 2.29 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the company earned $6.80 earnings per share. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Truist Financial boosted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Finally, Royal Bank Of Canada cut their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.